Batteson, Rachael
Hook, Emma
Wheat, Hollie
Hatswell, Anthony J.
Vioix, Helene
McLean, Thomas
Alexopoulos, Stamatia Theodora
Baijal, Shobhit
Paik, Paul K.
Funding for this research was provided by:
the healthcare business of Merck KGaA, Darmstadt, Germany
Article History
Accepted: 27 January 2024
First Online: 16 March 2024
Declarations
:
: This study was sponsored by Merck (CrossRef Funder ID: 10.13039/100009945). Medical writing support was provided by Delta Hat and funded by Merck.
: Helene Vioix and Stamatia Theodora Alexopoulos are employees of Merck. At the time of the analyses, Thomas McLean was an employee of Merck. Rachael Batteson, Emma Hook, Anthony Hatswell and Hollie Wheat are employees of Delta Hat, who were paid consultants for Merck. Shobit Baijal received consulting fees for advisory boards from Merck. Paul Paik holds an advisory role with IDEOlogy, Touch IME, Excerpta Medica, ACE Oncology, Physicians Education Resource, Medscape, Agile, Axis Medical Education, PeerVoice, Aptitude Health, MJH, Annenberg Center and Cardinal Health; receives grants from EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA and Bicara; consulting fees from Novartis, Mirati, Janssen and Bicara; and his research institution receives research expenses from Celgene and EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
: Not applicable.
: Not applicable.
: Not applicable.
: The data sets generated during and/or analysed during the current study are not publicly available because of patient confidentiality and data ownership. Any requests for data by qualified scientific and medical researchers for legitimate research purposes will be subject to Merck’s (CrossRef Funder ID: 10.13039/100009945) Data Sharing Policy. All requests should be submitted in writing to Merck’s data sharing portal (ExternalRef removed).
: Not applicable.
: RB drafted the initial manuscript. RB, EH and HW constructed the model. AH performed the statistical analysis to implement in the model. SB and PP provided expert clinical insights. HV, TM and STA reviewed the initial model and provided input into the overall structure and assumptions, as well as contributing to the original health technology assessment submissions from which the model was based. Data for inclusion within the model were provided by HV, via the pivotal clinical trial and supportive data collection exercises. All authors reviewed each version of the manuscript.